Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma

Published:2020-10-05 Issue:6 Volume:3 Page:287-290
ISSN:2577-171X
Container-title:IJU Case Reports
language:en
Short-container-title:IJU Case Reports

Author:

Hagimoto Hiroki¹^ORCID,Kashima Soki²³,Doi Kazuki¹,Nakayama Shintaro¹,Sano Takanori¹,Imai Satoshi¹^ORCID,Yasufuku Tomihiko¹,Muramaki Mototsugu¹,Yamada Yuji¹

Affiliation:

1. Department of Urology Hyogo Prefectural Amagasaki General Medical Center Amagasaki HyogoJapan

2. Department of Urology Kyoto University Graduate School of Medicine Kyoto KyotoJapan

3. Department of Urology Akita University Graduate School of Medicine Akita Akita Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iju5.12220

Reference18 articles.

1. Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma

2. One doze of immunotherapy leading to an exceptional and durable response in a patient with metastatic renal cell carcinoma;Wade L;Oxf. Med. Case Rep.,2019

3. PD-1 blockade induces responses by inhibiting adaptive immune resistance

4. Nivolumab versus everolimus in advanced renal‐cell carcinoma;Mottzer RJ;N. Engl. J. Med.,2015

5. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib;IJU Case Reports;2023-09-05

2. The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma;Cancers;2023-07-29

3. Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumab;IJU Case Reports;2022-04-26

4. A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma;Medicina;2022-02-23

5. Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma;IJU Case Reports;2020-10-07